next generation glp-1 The Revolution: How Next-Generation Obesity Drugs Are Reshaping the Global Healthcare Market Next-generation anti-obesity drugs: Mechanisms, molecules,

An editorial review of Ro vs Medvi program models, medication pathways, pricing tiers, and eligibility criteria

But another conversation has begun gaining momentum centered on fiber and the gut microbiome.

Then came the duals (like #tirzepatide), and even triagonists (#retatrutide) that pushed weight loss even farther

Pfizer plans to conduct dose optimization studies in the second half of 2024 evaluating multiple doses of the preferred modified release formulation to inform the registration enabling studies

AstraZeneca, Novo Nordisk A/S, Eli Lilly and Company, Sanofi and Hypera S.A

In late 2025, a seemingly narrow advertising dispute told a much bigger story about the GLP-1 market